Items Tagged with 'substance use'
ARTICLES
Expert Q&A
Navigating Cannabis Withdrawal
Alan J. Budney, PhD
Professor of Psychiatry; Professor of Biomedical Data Science; Geisel School of Medicine at Dartmouth, Lebanon, NH.
Dr. Budney has served as a scientific advisor for Jazz Pharmaceuticals and Indivior Inc. Relevant financial relationships listed for the author have been mitigated.
News of Note
Azstarys: Vyvanse’s Dexmethylphenidate Cousin
Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report.
Dr. Aiken has no financial relationships with companies related to this material.
Clinical Update
Three Buprenorphine Dosing Strategies When Transitioning From Other Opioids
Monthe Kofos, DO. Addiction Psychiatry Fellow, Yale University, New Haven, CT.
Noah Capurso, MD, MHS. Associate Professor of Psychiatry, Yale University, New Haven, CT; Editor-in-Chief, The Carlat Addiction Treatment Report.
Dr. Kofos and Dr. Capurso have no financial relationships with companies related to this material.
Expert Q&A
Substance-Induced Depression: Diagnosis and Treatment
Bryan K. Tolliver, MD, PhD
Associate professor, Addiction Sciences Division, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina. Charleston, SC.
Dr. Tolliver has no financial relationships with companies related to this material.
“When tailoring medication choice, a careful history can guide you. If I’m treating a patient who drinks excessively at night to sleep or who struggles with insomnia when they try to stop drinking, I’ll start with a sedating antidepressant like mirtazapine. That’s not an evidence-based decision, it’s a clinical decision that I think can be helpful.”
Carlat Total Access Subscriptions: Get access to every article on the website.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
Recommended
